Please use this identifier to cite or link to this item:
|Title:||A potential autocrine role for vascular endothelial growth factor in prostate cancer|
|Citation:||Cancer Research, 2002; 62(3):854-859|
|Publisher:||Amer Assoc Cancer Research|
|Michael W. Jackson, James S. Roberts, Susan E. Heckford, Carmela Ricciardelli, Jurgen Stahl, David J. Horsfall and Wayne D. Tilley|
|Abstract:||Vascular endothelial growth factor (VEGF) is a peptide growth factor specific for the tyrosine kinase receptors VEGF receptor-1 and -2 (VEGFR-1 and R-2). Whereas VEGF has well-defined actions on the vasculature, including the stimulation of endothelial cell growth and motility and blood vessel permeability, the function of the VEGF/ receptor pathway in other cell types is largely unknown. Recently, VEGFR-1 and R-2 expression has been reported in prostate tumor cells. In this study, we demonstrate that these receptors colocalize with VEGF in prostate tumor cells, prostatic intraepithelial neoplasia, and the basal cells of normal glands. Furthermore, in comparison with normal glands, the expression of VEGFR-1 and R-2 is increased in prostatic intraepithelial neoplasia and malignant cells in well and moderately differentiated prostate cancer but is decreased in poorly differentiated cancer. Culture of the prostate cancer cell line LNCaP in the presence of recombinant human VEGF165 resulted in a 50% increase in [3H]thymidine uptake by these cells and recruitment of quiescent cells into the cell cycle. This effect of recombinant human VEGF165 was abolished by neutralizing antisera to VEGFR-2. These data suggest that VEGF may not only mediate neovascularization associated with prostate cancer progression but may also directly stimulate prostate tumor cells via VEGFR-2-dependent autocrine and/or paracrine mechanisms.|
|Keywords:||Tumor Cells, Cultured; Epithelial Cells; Humans; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Neovascularization, Pathologic; Receptor Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors; Vascular Endothelial Growth Factor A; Endothelial Growth Factors; Receptors, Growth Factor; Proto-Oncogene Proteins; Recombinant Proteins; DNA, Neoplasm; Lymphokines; Immunoblotting; S Phase; Male|
|Rights:||© 2002 American Association for Cancer Research|
|Appears in Collections:||Obstetrics and Gynaecology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.